Stocks · Healthcare · Biotechnology
Ovid Therapeutics Inc. OVID
$2.34 -1.68% Close, Oct 5, 2026 · NASDAQ · Market cap $444.2M
High risk
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $1.6M, down 76.2% from a year earlier, slowing from 1199.6% a quarter earlier.
- Operating margin narrowed to -3686.7% from -625.0% a year earlier.
- The stock is in an uptrend: above its 200-day average for 288 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 7%
- Revenue growth, 3-year CAGRTop 9%
- Revenue growth accelerationBottom 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 45%
- Gross marginTop 2%
- Operating marginBottom 8%
- Accruals (lower is better)Bottom 8%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 32%
- Free-cash-flow yieldBottom 33%
- EBITDA / enterprise valueBottom 43%
- Sales / enterprise valueBottom 5%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 25%
- 6-month returnBottom 43%
- 1-year return vs S&P 500Top 30%
- Distance from 52-week highTop 39%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 14%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 48%
- Upside to consensus price targetTop 23%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 40%
- Maximum drawdown, 3 yearsBottom 8%
- Beta vs S&P 500 (lower is better)Bottom 13%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1199.6% | -76.2% | ↓ |
| Gross margin | 100.0% | 100.0% | → |
| Operating margin | -625.0% | -3686.7% | ↓ |
| FCF margin | -602.7% | -3460.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -76.2% | 1199.6% | ↓ | Bottom 7% |
| Gross margin | 100.0% | 100.0% | → | Top 2% |
| Operating margin | -3686.7% | -625.0% | ↓ | Bottom 8% |
| Net margin | -2178.9% | -574.0% | ↓ | — |
| Free-cash-flow margin | -3460.1% | -602.7% | ↓ | — |
| Return on invested capital | -26.1% | — | Bottom 45% | |
| Revenue growth, 3-year CAGR | 69.0% | — | Top 9% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 8.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 165.9%
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -41.82%
- Shareholder yield
- -41.82%
- Share count change, 1 year
- +3.7%
- Share count change, 3-year CAGR
- +1.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +44.3%
- Average 2-day reaction, last 8
- +8.1%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $6.50
- Target vs current price
- +177.8%
- Analysts with a rating
- 14
- Share rating Buy or Strong Buy
- 79%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +30.4% | +6.9% | +11.8% | +0.4% | — |
| May 12, 2026 | +0.0% | +2.9% | -13.6% | -13.3% | -5.0% |
| Mar 18, 2026 | +160.0% | +14.4% | +20.4% | +37.3% | +10.0% |
| Nov 12, 2025 | -13.3% | -2.2% | -2.2% | +20.0% | +17.0% |
| Aug 13, 2025 | +62.5% | +56.9% | +71.8% | +128.5% | +143.1% |
| May 13, 2025 | +0.0% | -5.3% | -0.3% | +6.3% | +69.4% |
| Mar 11, 2025 | +18.8% | +0.1% | -4.8% | -41.2% | -36.8% |
| Nov 12, 2024 | -5.3% | -8.8% | -23.5% | -16.2% | -52.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.08 | -$0.12 | +30.4% | $733,000 |
| May 12, 2026 | -$0.12 | -$0.12 | +0.0% | — |
| Mar 18, 2026 | $0.06 | -$0.10 | +160.0% | $718,000 |
| Nov 12, 2025 | -$0.17 | -$0.15 | -13.3% | $132,000 |
| Aug 13, 2025 | -$0.06 | -$0.16 | +62.5% | $6.3M |
| May 13, 2025 | -$0.14 | -$0.14 | +0.0% | $130,000 |
| Mar 11, 2025 | -$0.13 | -$0.16 | +18.8% | $76,000 |
| Nov 12, 2024 | -$0.20 | -$0.19 | -5.3% | $173,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 281.49× | — | — | Bottom 5% |
| Free-cash-flow yield | -12.33% | — | — | Bottom 33% |
| Earnings yield | -20.51% | — | — | Bottom 32% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 288
- 50-day average slope (20 days)
- +0.9%
- 200-day average slope (20 days)
- +4.7%
- Distance from 50-day average
- -11.3%
- Distance from 200-day average
- +1.7%
- RSI (14)
- 35.0
- Relative volume
- 0.67×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 50.0%
- Volatility vs own 5-year history
- 28th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.03
- Correlation with S&P 500
- 0.29
- Current drawdown from 1-year high
- -20.9%
- Maximum drawdown, 3 years
- -93.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 30, 2020 | Apr 8, 2025 | -96.3% | 1093 days | Not yet recovered |
| Oct 7, 2020 | Nov 2, 2020 | -19.9% | 18 days | 18 days (Nov 27, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $444.2M
- EPS, diluted (TTM)
- -$0.48
- Revenue (TTM)
- $1.6M
- 52-week range
- $1.18 – $3.11
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $208.4M | $1.5M | $392,000 | $566,000 | $7.3M |
| Gross profit | $208.4M | $1.5M | $392,000 | $566,000 | $7.0M |
| Operating income | $124.2M | -$55.5M | -$59.3M | -$61.9M | -$42.4M |
| Net income | $122.8M | -$54.2M | -$52.3M | -$26.4M | -$17.4M |
| EPS (diluted) | $1.76 | -$0.77 | -$0.74 | -$0.37 | -$0.24 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $173,000 | $76,000 | $130,000 | $6.3M | $132,000 | $718,000 | $0 | $733,000 |
| Net income | -$14.0M | -$9.3M | -$10.2M | -$4.7M | -$12.2M | $9.7M | -$17.0M | -$15.0M |
| EPS (diluted) | -$0.20 | -$0.13 | -$0.14 | -$0.07 | -$0.17 | $0.12 | -$0.23 | -$0.20 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $118.6M | -$55.2M | -$45.8M | -$56.0M | -$38.3M |
| Capital expenditure | -$189,408 | -$1.4M | -$137,455 | -$71,000 | $0 |
| Free cash flow | $118.4M | -$56.6M | -$45.9M | -$56.0M | -$38.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $925,396 | $180,658 | $535,201 | $622,000 | $75.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $117.2M
- Total assets
- $232.0M
- Total liabilities
- $22.1M
- Total debt
- $12.7M
- Net debt
- $1.4M
- Shareholders’ equity
- $209.9M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 21,151,179
- Days to cover
- 17.25
- Change vs previous report
- +2.3%
FINRA short interest, settlement date Sep 15, 2026.